Molflu is expected to be available from early next week in pharmacies throughout the country with a particular focus on states with a high caseload of Covid-19.
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
The newly launched centre in Mumbai is part of the company’s ambition to be present in 100 cities across the country within two years.”
Zeebon is the largest diagnostics services provider in North-Eastern states
The product is expected to be available in a week’s time
It plans to deliver over 300 million doses to the Indian government
The drug will be marketed under the brand name Molnaflu
The single-dose vaccine has been approved in China, Mexico, Ecuador, Chile, Argentina, Hungary, Kirghizstan, Pakistan, Indonesia and Malaysia
After specialising in laparoscopy, proctology, urology, and cosmetic surgeries, Glamyo Health is now venturing into orthopaedic surgeries
Subscribe To Our Newsletter & Stay Updated
